Evidence map›Paper›PMID 32571131›Full record

ArticleImmunotherapy2020

Long-term control of leptomeningeal disease after radiation therapy and nivolumab in a metastatic melanoma patient.

Richard C Wu, William Newman, Liron Patanowitz, Barton F Branstetter, Nduka Amankulor, Ahmad A Tarhini

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Immunotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Richard C WuDivision of Oncology, UPMC Cancer Center, Pittsburgh, PA 15232, USA.ORCID 0000-0002-7869-8416
William NewmanDepartment of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
Liron PatanowitzDepartment of Pathology, UPMC Cancer Center, Pittsburgh, PA 15232, USA.
Barton F BranstetterDepartment of Neuro-Radiology, University of Pittsburgh Medical Center, Pittsburgh, PA 15232, USA.
Nduka AmankulorDepartment of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
Ahmad A TarhiniDepartment of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
University of Pittsburgh Medical Center · USMoffitt Cancer Center · US

Funding

Training in Cancer Therapeutics ResearchT32CA193205 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BUCKANOVICH, RONALD J · 2015 to 2019
$893k
NCI NIH HHS T32 CA193205
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAntineoplastic Agents, ImmunologicalBrain NeoplasmsFatal OutcomeHumansMaleMelanomaMeningesMutationNivolumabProgrammed Cell Death 1 ReceptorProto-Oncogene Proteins B-rafRadioimmunotherapyRemission InductionSpinal Cord DiseasesAntineoplastic Agents, ImmunologicalNivolumabPDCD1 protein, humanProgrammed Cell Death 1 ReceptorProto-Oncogene Proteins B-rafCNS cancerimmunotherapyleptomeningeal diseasemelanomaPD-1

Identifiers

PMID32571131
PMCPMC7421879
OpenAlexW3036280511

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.